Research output per year
Research output per year
Personal profile
Research interests
Leukemia, stem cell mobilization, glioblastoma
Clinical interests
Leukemia, MDS, brain tumors, melanoma oncology
Fingerprint
Dive into the research topics where George Ansstas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma
Damato, A. R., Katumba, R. G. N., Luo, J., Atluri, H., Talcott, G. R., Govindan, A., Slat, E. A., Weilbaecher, K. N., Tao, Y., Huang, J., Butt, O. H., Ansstas, G., Johanns, T. M., Chheda, M. G., Herzog, E. D., Rubin, J. & Campian, J., May 1 2022, In: Neuro-Oncology Practice. 9, 3, p. 193-200 8 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma
Mehnert, J. M., Mitchell, T. C., Huang, A. C., Aleman, T. S., Kim, B. J., Schuchter, L. M., Linette, G. P., Karakousis, G. C., Mitnick, S., Giles, L., Carberry, M., Frey, N., Kossenkov, A., Groisberg, R., Hernandez-Aya, L. F., Ansstas, G., Silk, A. W., Chandra, S., Sosman, J. A., Gimotty, P. A., & 2 others, Mar 15 2022, In: Clinical Cancer Research. 28, 6, p. 1098-1106 9 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
BESPOKE IO protocol: A multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours
Kasi, P. M., Chakrabarti, S., Sawyer, S., Krainock, M., Poklepovic, A., Ansstas, G., Maninder, M., Malhotra, M., Ensor, J., Gao, L., Eroglu, Z., Ellers, S., Billings, P., Rodriguez, A. & Aleshin, A., May 30 2022, In: BMJ Open. 12, 5, e060342.Research output: Contribution to journal › Article › peer-review
Open Access -
Biomarker-Driven Prognostication in Merkel Cell Carcinoma: A Paradigm for Personalized Therapy
Helmink, B. A., Ansstas, G. & Fields, R., Mar 2022, In: Annals of Surgical Oncology. 29, 3, p. 1498-1501 4 p.Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
CD33 mRNA Has Elevated Expression Levels in the Leukocytes of Peripheral Blood in Patients with Late-Onset Alzheimer's Disease
Heidari, F., Ansstas, G. & Ajamian, F., May 1 2022, In: Gerontology. 68, 4, p. 421-430 10 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations